2Garzon, E. , R.M. Fernandes, and A. C. Sakamoto, Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure, 2003,12 (6) :337-345.
3Rossetti, A. O. , G. Eogroscino, and E.B. Bromfield, A clinical score for prognosis of status epilepticus in adults. Neurology, 2006, 66( 11 ) :1736-1738.
1[1]Husain AM,Horn GJ,Jacobson MP.Non-convulsive status epilepticus:usefulness of clinical features in selecting patients for urgent EEG[J].J Neurol Neurosurg Psychiatry,2003,74(2):198～91.
2[2]Walker MC.Status epilepticus on the intensive care unit[J].J Neurol,2003,250(4):401～6.
3[3]R Appleton,I Choonara,T Martland,B Phillips,R Scott,W Whitehouse.The treatment of convulsive status epilepticus in children[J].Arch Dis Child,2000,83:415～9.
4[4]Parviainen I,Uusaro A,Kalviainen R,Kaukanen E,Mervaala E,Ruokonen E.High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit[J].Neurology,2002,59(8):1249～51.
5[5]Kahriman M,Minecan D,Kutluay E,et al.Efficacy of topiramate in children with refractory status epilepticus[J].Epilepsia,2003,44(10):1353～6.
6[6]Niermeijer JM,Uiterwaal CS,Van Donselaar CA.Propofol in status epilepticus:little evidence,many dangers[J]?J Neurol,2003,250(10):1237～40.
7[7]Stecker MM,Kramer TH,Raps EC,et al.Treatment of refractory status epilepticus with propofol:clinical and pharmacokinetic findings[J].Epilepsia,1998,39(1):18～26.
8Mayer SA,Claassen J,Lokin J,et al. Refractory status epileticus: frequency,risk factors,and impact on outcome [J].Arch Neurol, 2002; 59(2): 205.
9Thulasimani M,Ramaswamy S.The role of paraldehyde and lidocaine in the management of status epilepticus[J]. Anaesthesia, 2002; 57(1): 99.
10Lowenstein DH, Alldredge BK. Status epilepticus [J]. N Engl J Med, 1998;338(14):970.
